Number of generics override needed B4 approval of Category and rejected Drug covered in category Grandfathering Overrides Scriptwise Message 2 Antihypertensives - brand ARBs Cozaar (Losartan) Hyzaar (Losartan Hydrochlorothiazide) Teveten HCT (Eprosartan/Hydrochlorothiazide)· Exforge · Valturna 3 niacin containing products- not covered AT AL
- A |
J |K |
U |V |
Microsoft word - shl-communication policy 2012 _r1_.doc(Incorporated in Bermuda with limited liability) Starlite Holdings Limited (the “Company”) is committed to enhancing long-term shareholder value through regular communication with its shareholders, both individual and institutional (the “Shareholders”). To this end, the Company strives to ensure that all Shareholders have ready and timely access to all publicly available information of the Company. The Company sets out in this Policy the framework that it has put in place to promote effective communication with Shareholders so as to enable them to engage actively with the Company and exercise their rights as shareholders in an informed manner. The annual general meetings and other general meetings of the Company are the primary forum for communication with Shareholders and for Shareholder The Company encourages Shareholders to participate in shareholders’ meetings physically or to appoint proxies to attend and vote at such meetings for and on their Notices of general meetings and the accompanying papers are provided within a prescribed time prior to the meetings on the websites of the Company (www.hkstarlite.com), irasia.com Limited (www.irasia.com/listco/hk/starlite) and Hong Kong Exchanges and Clearing Limited (“HKEX”) (www.hkexnews.hk), and by post to the Shareholders. Shareholders’ meetings are held at a convenient location where the Chairman of the Board of the Company, Directors, and if required, Chairmen of Board committees and representatives from the auditor would be present and are available to answer questions from Shareholders. The Company reports operating results on a half yearly basis and produces interim and annual reports in accordance with the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (“HKEX”) and other applicable laws and regulations (the “Regulatory Requirements”). From time to time, the Company communicates other information to Shareholders by way of Company’s announcement and/or circular, in compliance with the Regulatory The Company’s website (www.hkstarlite.com) provides updated information of the Company, including shareholders communication. The “Investor Relations” section of the Company’s website is posted with the annual reports, interim reports, announcements and circulars of the Company as soon as practicable following the release of the respective documents on the website of Shareholders may, at any time, direct questions, request for publicly available information and provide comments and suggestions to Directors or management of the Company. Such questions, requests and comments can be addressed to the Company Secretary of the Company by mail to 3/F., Perfect Industrial Building, 31 Tai Yau Street, Sanpokong, Kowloon, Hong Kong or by email to Shareholders should direct their questions about their shareholdings by mail to the Company’s Hong Kong Branch Share Registrar and Transfer Office, Tricor Secretaries Limited, at 26/F., Tesbury Centre, 28 Queens’ Road East, Hong Kong or by e-mail to [email protected], who has been appointed by the Company to deal with Shareholders for share registration and related matters.
Sicherheitsdatenblatt gemäß Verordnung (EG) Nr. 1907/2006 (REACH) Druckdatum 1.09.2007 Überarbeitet 17.02.2009 (D) Killgerm Anti-Insekt RTU Stoff-/Zubereitungs- und Firmenbezeichnung Angaben zum Produkt Handelsname: Killgerm Anti-Insekt RTU Art des Präparates: A n we n d u n g s f e r t i g e s L a n g z e i t i ns e k t i z i d z u m S p r ü h e n Anschrift des Lief